A medical adhesive with good biodegradable performance capable of undergoing crosslinking copolymerization, comprising a mono-alpha-cyanoacrylate and a bis-alpha-cyanoacrylic acid diol ester monomer molecule. The olefinic bonds in the mono-alpha-cyanoacrylate structure are polymerized in the presence of infinitesimal anions to form a solid 3D high polymer; the 3D high polymer is provided with degradation sites on the web-like backbone chain, with clear degradation path and absorbable degradation products. The medical adhesive can be used for wound adhesive, large area wound hemostasia, and visceral and soft tissue wound closure.

A medical adhesive with good biodegradable performance capable of undergoing crosslinking copolymerization, comprising a mono-alpha-cyanoacrylate and a bis-alpha-cyanoacrylic acid diol ester monomer molecule. The olefinic bonds in the mono-alpha-cyanoacrylate structure are polymerized in the presence of infinitesimal anions to form a solid 3D high polymer; the 3D high polymer is provided with degradation sites on the web-like backbone chain, with clear degradation path and absorbable degradation products. The medical adhesive can be used for wound adhesive, large area wound hemostasia, and visceral and soft tissue wound closure.

Provided is an optical laminate which has high absorption selectivity to short-wavelength visible light having wavelengths around 400 nm and hence high light fastness and can impart better display characteristics when used for a display device. The optical laminate comprises at least one polarizing plate and at least one pressure-sensitive adhesive layer and satisfying the following formulae (1) and (2):

A(400)0.5(1)

A(420)/A(400)0.3(2) where A(400) represents the absorbance of the optical laminate at a wavelength of 400 nm in the transmission direction of the polarizing plate and A(420) represents the absorbance of the optical laminate at a wavelength of 420 nm in the transmission direction of the polarizing plate.

The present invention concerns a two-part curable composition comprising: a) a first part (part A) comprising:at least one cyanoacrylate monomer; b) a second part (part B) comprising:a nucleophilic initiator;a plasticizer; said two-part curable composition further comprising a color changing indicator in part A and/or part B; said nucleophilic initiator being selected from the group consisting of: organic bases, quaternary ammonium salts, metal salts of carboxylic acids, and mixtures thereof. The present invention also concerns its use, in particular for determining cure of said composition.

The invention relates to a nanoparticle comprising copolymeric or homopolymeric compounds which comprise cyanoacrylate subunits according to formula 2A, wherein each R.sup.1 is independently selected from the group consisting of 2-ethylhexyl, 2-phenylethyl, neopentyl, 1-pentyl, 2-pentyl, 3-pentyl, 3,3-dimethyl-1-butyl, 3-methylbutyl, -heptyl, 2-heptyl, and 3-heptyl; and wherein the nanoparticle further comprises an active agent. The invention also provides compositions comprising the nanoparticles, and the nanoparticles for use in therapy or diagnosis, such as in the treatment of cancer or an infection, or for use in diagnostic imaging.

The invention relates to a nanoparticle comprising copolymeric or homopolymeric compounds which comprise cyanoacrylate subunits according to formula 2A, wherein each R.sup.1 is independently selected from the group consisting of 2-ethylhexyl, 2-phenylethyl, neopentyl, 1-pentyl, 2-pentyl, 3-pentyl, 3,3-dimethyl-1-butyl, 3-methylbutyl, -heptyl, 2-heptyl, and 3-heptyl; and wherein the nanoparticle further comprises an active agent. The invention also provides compositions comprising the nanoparticles, and the nanoparticles for use in therapy or diagnosis, such as in the treatment of cancer or an infection, or for use in diagnostic imaging.